NCT00283426View on ClinicalTrials.gov

Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns

PHASE1TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

March 31, 2007

Conditions
Burns
Interventions
DRUG

Soluble beta-1,3/1,6-glucan

Trial Locations (1)

5021

Haukeland University Hospital, Bergen

Sponsors
All Listed Sponsors
lead

Biotec Pharmacon ASA

INDUSTRY

NCT00283426 - Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns | Biotech Hunter | Biotech Hunter